Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder.

Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, Mann JJ, Postolache TT.

Brain Behav Immun. 2011 Aug;25(6):1272-8. doi: 10.1016/j.bbi.2011.05.002. Epub 2011 May 14.

2.

The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.

Bradley KA, Case JA, Khan O, Ricart T, Hanna A, Alonso CM, Gabbay V.

Psychiatry Res. 2015 Jun 30;227(2-3):206-12. doi: 10.1016/j.psychres.2015.03.031. Epub 2015 Apr 1.

3.

The possible role of the kynurenine pathway in adolescent depression with melancholic features.

Gabbay V, Klein RG, Katz Y, Mendoza S, Guttman LE, Alonso CM, Babb JS, Hirsch GS, Liebes L.

J Child Psychol Psychiatry. 2010 Aug;51(8):935-43. doi: 10.1111/j.1469-7610.2010.02245.x. Epub 2010 Apr 12.

4.

Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?

Quak J, Doornbos B, Roest AM, Duivis HE, Vogelzangs N, Nolen WA, Penninx BW, Kema IP, de Jonge P.

Psychoneuroendocrinology. 2014 Jul;45:202-10. doi: 10.1016/j.psyneuen.2014.03.013. Epub 2014 Apr 5.

PMID:
24845191
5.

Tryptophan and Kynurenine Metabolites: Are They Related to Depression?

Pompili M, Lionetto L, Curto M, Forte A, Erbuto D, Montebovi F, Seretti ME, Berardelli I, Serafini G, Innamorati M, Amore M, Baldessarini RJ, Girardi P, Simmaco M.

Neuropsychobiology. 2019;77(1):23-28. doi: 10.1159/000491604. Epub 2018 Aug 15.

PMID:
30110684
6.

The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.

Sorgdrager FJH, Doornbos B, Penninx BWJH, de Jonge P, Kema IP.

J Affect Disord. 2017 Nov;222:32-39. doi: 10.1016/j.jad.2017.06.052. Epub 2017 Jun 24.

PMID:
28668713
7.

Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.

Mukherjee D, Krishnamurthy VB, Millett CE, Reider A, Can A, Groer M, Fuchs D, Postolache TT, Saunders EFH.

Bipolar Disord. 2018 Feb;20(1):27-34. doi: 10.1111/bdi.12529. Epub 2017 Aug 23.

8.

Kynurenine pathway changes in late-life depression.

Wu Y, Zhong X, Mai N, Wen Y, Shang D, Hu L, Chen B, Zhang M, Ning Y.

J Affect Disord. 2018 Aug 1;235:76-81. doi: 10.1016/j.jad.2018.04.007. Epub 2018 Apr 3.

PMID:
29655078
9.

Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.

Messaoud A, Mensi R, Douki W, Neffati F, Najjar MF, Gobbi G, Valtorta F, Gaha L, Comai S.

World J Biol Psychiatry. 2018 May 23:1-9. doi: 10.1080/15622975.2018.1468031. [Epub ahead of print]

PMID:
29683396
10.

The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.

Guloksuz S, Arts B, Walter S, Drukker M, Rodriguez L, Myint AM, Schwarz MJ, Ponds R, van Os J, Kenis G, Rutten BP.

Brain Behav Immun. 2015 Aug;48:48-52. doi: 10.1016/j.bbi.2015.02.029. Epub 2015 Mar 9.

PMID:
25765557
11.

Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.

Mangge H, Summers KL, Meinitzer A, Zelzer S, Almer G, Prassl R, Schnedl WJ, Reininghaus E, Paulmichl K, Weghuber D, Fuchs D.

Obesity (Silver Spring). 2014 Jan;22(1):195-201. doi: 10.1002/oby.20491. Epub 2013 Jul 5.

12.

Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy.

Groer M, Fuchs D, Duffy A, Louis-Jacques A, D'Agata A, Postolache TT.

Biol Res Nurs. 2018 May;20(3):284-291. doi: 10.1177/1099800417738363. Epub 2017 Nov 15.

PMID:
29141444
13.

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH.

Mol Psychiatry. 2010 Apr;15(4):393-403. doi: 10.1038/mp.2009.116. Epub 2009 Nov 17.

14.

Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers.

Dahl J, Andreassen OA, Verkerk R, Malt UF, Sandvik L, Brundin L, Ormstad H.

Psychoneuroendocrinology. 2015 Jun;56:12-22. doi: 10.1016/j.psyneuen.2015.02.011. Epub 2015 Feb 25.

PMID:
25770856
15.

Possible changes of New-Generation inflammation markers with occupational lead exposure.

Sipahi H, Girgin G, Palabiyik SS, Tutkun E, Yilmaz OH, Baydar T.

J Occup Health. 2017 Jul 27;59(4):345-351. doi: 10.1539/joh.16-0273-OA. Epub 2017 Jun 7.

16.

Positron emission tomography quantification of serotonin(1A) receptor binding in suicide attempters with major depressive disorder.

Sullivan GM, Oquendo MA, Milak M, Miller JM, Burke A, Ogden RT, Parsey RV, Mann JJ.

JAMA Psychiatry. 2015 Feb;72(2):169-78. doi: 10.1001/jamapsychiatry.2014.2406.

17.

Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.

Brandacher G, Cakar F, Winkler C, Schneeberger S, Obrist P, Bösmüller C, Werner-Felmayer G, Werner ER, Bonatti H, Margreiter R, Fuchs D.

Kidney Int. 2007 Jan;71(1):60-7. Epub 2006 Nov 15.

18.

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.

Widner B, Leblhuber F, Fuchs D.

J Neural Transm (Vienna). 2002 Feb;109(2):181-9.

PMID:
12075858
19.

Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients.

Durastanti V, Lugaresi A, Bramanti P, Amato M, Bellantonio P, De Luca G, Picconi O, Fantozzi R, Locatelli L, Solda' A, Sessa E, Totaro R, Marino S, Zipoli V, Zorzon M, Millefiorini E.

J Transl Med. 2011 Apr 18;9:42. doi: 10.1186/1479-5876-9-42.

20.

Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression.

Ormstad H, Dahl J, Verkerk R, Andreassen OA, Maes M.

Eur Neuropsychopharmacol. 2016 Aug;26(8):1286-96. doi: 10.1016/j.euroneuro.2016.05.005. Epub 2016 May 26.

PMID:
27237997

Supplemental Content

Support Center